Regulated Building Materials Survey Report.pdf

p

REG

ULATED BUI

LDING MATERIALS

SURVEY REPORT

A/E Design Services for Pharmacy Physical Security Upgrades VA Project No. 586-22-105

G.V. Sonny Montgomery VAMC 1500 E. Woodrow Wilson Avenue Jackson, MS 39216

Mabbett Project No. R2023038.000

April 30, 2023v2

Prepared For:

Miller-Remick, LLC.

1040 Kings Highway North Suite 700 Cherry Hill, NJ 08034

© 2023, Mabbett & Associates, Inc.

Mabbett & Associates, Inc. www.mabbett.com 105 Central Street, Suite 4100 Stoneham, MA 02180-1260 T. 781-275-6050 F: 781-954-5155

Massachusetts | Virginia | Rhode Island | New York

REGULATED BUILDING MATERIALS SURVEY REPORT

A/E Design Services for Pharmacy Physical Security Upgrades | G.V. Sonny Montgomery VAMC | Jackson, MS

© 2023, Mabbett & Associates, Inc. i April 30, 2023 Project No. R2023038.000 Miller-Remick Jackson VAMC Pharmacy RBM Survey Report Final

ACKNOWLEDGEMENT

This Regulated Building Materials Survey Report has been prepared by Mabbett & Associates, Inc. (Mabbett®) for the A/E Design Services for Pharmacy Physical Security Upgrades at the G.V. Sonny Montgomery VAMC located in Jackson, Mississippi. The information presented herein is based on the facts and information conveyed to or received by Mabbett during the preparation of this report. If any of the information provided to Mabbett that was used in preparing this report is incorrect, incomplete, or subject to change, Mabbett would wish to alter its opinions accordingly. In addition, the professional opinions and information contained in this report are based solely on the requirements of the applicable regulations and technical data as known to Mabbett as of the date of this report and considered applicable to this report.

Mabbett does not claim to have identified all hazardous materials that could be present in the facility. Mabbett has conducted this assessment with reasonable care and has performed this project in accordance with industry standards. There can be no assurances, and Mabbett makes no assurances, that the information, research, and technology used to prepare this report may not change in the future, thus affecting the results reported herein.

The attached Regulated Building Materials Survey Report was prepared by Mr. Kevin M. Donovan, Senior Environmental, Health & Safety Specialist of Mabbett & Associates, Inc.

This report has been reviewed and approved by:

Michael F. Delaney Director, Building Sciences Group

KMD/MFD:fmz

A/E Design Services for Pharmacy Physical Security Upgrades | G.V. Sonny Montgomery VAMC | Jackson, MS

© 2023, Mabbett & Associates, Inc. ii April 30, 2023 Project No. R2023038.000 Miller-Remick Jackson VAMC Pharmacy RBM Survey Report Final

TABLE OF CONTENTS

SECTION PAGE

1.0 INTRODUCTION

2.0 ASBESTOS CONTAINING MATERIAL (ACM) SURVEY

2.1 Sampling Methodology

2.2 Analytical Methodology

2.3 ACM Results

3.0 LEAD CONTAINING PAINT (LCP) SURVEY

3.1 Sampling Methodology

3.2 Analytical Methodology

3.3 LCP Results

4.0 RECOMMENDATIONS

4.1 Asbestos

4.2 Lead Containing Paint

TABLES

Table 1 - Estimated Quantities of ACM

Table 2 - Paint Chip Analytical Results

APPENDICES

Appendix A – Summary of Asbestos Bulk Sampling Results Appendix B – ECS Southeast Asbestos Survey Report Appendix C – LCP Lab Report and Chain of Custody

A/E Design Services for Pharmacy Physical Security Upgrades | G.V. Sonny Montgomery VAMC | Jackson, MS

© 2023, Mabbett & Associates, Inc. Page 1 April 30, 2023 Project No. R2023083.000 Miller-Remick Jackson VAMC Pharmacy RBM Survey Report Final

1.0 INTRODUCTION

Mabbett and Associates, Inc. (Mabbett®), with support from local asbestos inspection consulting firm ECS Southeast, LLP (ECS), performed a survey for regulated building materials (RBM) as part of the A/E Design Services for Pharmacy Physical Security Upgrades at the G.V. Sonny Montgomery VAMC located in Jackson, Mississippi, VA Project No. 586-22-105. The survey was limited to the basement level inpatient pharmacy and first floor outpatient pharmacy. Site survey work was performed on April 13th, 2023, by Certified Asbestos Inspector Mr.

Kevin Donovan of Mabbett and Mississippi licensed asbestos inspector Mr. Taylor L Pack (ABI-00011150) and consisted of the following activities:

Asbestos Containing Material (ACM) survey of suspect materials [analysis by Polarized Light Microscopy

(PLM).

Lead Containing Paint (LCP) sampling (analysis by Flame Atomic Absorption Spectrophotometry [AA].

A/E Design Services for Pharmacy Physical Security Upgrades | G.V. Sonny Montgomery VAMC | Jackson, MS

© 2023, Mabbett & Associates, Inc. Page 2 April 30, 2023 Project No. R2023083.000 Miller-Remick Jackson VAMC Pharmacy RBM Survey Report Final

2.0 ASBESTOS CONTAINING MATERIAL (ACM) SURVEY

A visual screening inspection was conducted to identify locations of suspect ACM and to design the sampling program. Only areas that may be impacted by the renovation and physical security upgrades in the pharmacy’s project and that were accessible during the survey were inspected with reasonable efforts made to access pertinent areas. Destructive investigation of operating equipment was not conducted.

2.1 Sampling Methodology

Bulk suspect ACM samples were collected using EPA National Emissions Standards for Hazardous Air Pollutants (NESHAP), 40 CFR Part 763. This method describes sampling for friable surfacing material, thermal system insulation, and miscellaneous material. Asbestos Hazard Emergency Response Act (AHERA) protocols were also employed. Suspect ACM sampling was conducted according to the following standard sampling protocol:

Friable surfacing material:

• At least three bulk samples shall be collected from each homogeneous area of surfacing material that is 1,000 ft2 or less.

• At least five bulk samples shall be collected from each homogeneous area of surfacing material that is greater than 1,000 ft2 but less than or equal to 5,000 ft2.

• At least seven bulk samples shall be collected from each homogeneous area of surfacing material that is greater than 5,000 ft2.

Thermal system insulation:

• At least three bulk samples shall be collected from each homogeneous area of thermal system insulation.

• At least one bulk sample shall be collected from each homogeneous area of patched thermal system insulation.

• Sufficient samples shall be collected from elbows and fittings.

• Bulk samples shall not be collected from any homogeneous area where the inspector determines that the thermal system insulation is fiberglass, foam glass, rubber, or other non-ACM.

Miscellaneous material (e.g., joint compound, roofing, gaskets, floor coverings, decorative coatings, wire insulation).

• At least two bulk samples shall be collected from each homogeneous area of miscellaneous material that is less than 100 ft2.

• At least three bulk samples shall be collected from each homogeneous area of miscellaneous material that is greater than 100 ft2.

Areas that were inaccessible or where the survey was limited to visual observation only:

within walls within enclosed pipe/duct chases inside mechanical equipment/ductwork inside electrical equipment

A/E Design Services for Pharmacy Physical Security Upgrades | G.V. Sonny Montgomery VAMC | Jackson, MS

© 2023, Mabbett & Associates, Inc. Page 3 April 30, 2023 Project No. R2023083.000 Miller-Remick Jackson VAMC Pharmacy RBM Survey Report Final

2.2 Analytical Methodology

Seventy (70) bulk samples were collected from twenty-four (24) homogeneous areas and submitted under chain of custody (COC) procedures to EMSL Analytical, Inc. of Baton Rouge, Louisiana (NVLAP Laboratory ID 200375-0).

Bulk samples were analyzed by PLM using AHERA method 40CFR 763 with EPA Method 600/R-93/116 using polarized light microscopy.

2.3 ACM Results

The USEPA, Occupational Safety and Health Administration (OSHA), and the Mississippi Department of Environmental Quality (MDEQ) define any material that contains greater than one percent (>1%) asbestos as ACM.

One (1) material was found to contain greater than one percent (>1%) asbestos. Asbestos Bulk Sampling Results are summarized in Appendix A. The laboratory report and COC documentation are provided in Appendix B, ECS Asbestos Survey Report, dated April 21, 2023.

Estimated quantities of materials identified as ACM are presented in Table 1.

Table 1 Estimated Quantities of ACM

A/E Design Services for Pharmacy Physical Security Upgrades G.V. Sonny Montgomery VAMC

Location Description of Material Percent and Type of Asbestos Estimated Quantity

Outpatient Pharmacy Red Duct Sealant 10% Chrysotile 100 Square Feet

Mabbett also observed fire doors on the 1st floor which were not accessible for inspection or sampling. Fire doors material are assumed ACM.

A/E Design Services for Pharmacy Physical Security Upgrades | G.V. Sonny Montgomery VAMC | Jackson, MS

© 2023, Mabbett & Associates, Inc. Page 4 April 30, 2023 Project No. R2023083.000 Miller-Remick Jackson VAMC Pharmacy RBM Survey Report Final

3.0 LEAD CONTAINING PAINT (LCP) SURVEY

An LCP survey was conducted by collecting and analyzing paint chips from painted surfaces and systems that may be impacted by the pharmacy renovate/physical security upgrades project.

3.1 Sampling Methodology

Paint chip samples are collected using a sharp hand tool to score and peel paint off a 1 square inch (or larger) area of the substrate. Different tools such as chisels, putty knives, and hammers may also be needed in the collection of paint chips. Tools are cleaned after each sample to prevent cross contamination. Collected paint chip samples are submitted under COC procedures to an accredited laboratory and analyzed via Flame Atomic Absorption Spectrophotometry (AA).

3.2 Analytical Methodology

The regulations addressing LCP in non-residential buildings are focused on occupational exposures involved with paint-disturbing activities and related waste-disposal activities. Occupational exposure to lead is regulated by OSHA regulation 29 CFR 1926.62, Lead in Construction, as well as other applicable state and local regulations. An LCP survey cannot determine a safe level of lead for the purpose of paint-disturbing/waste-disposal activities but is intended to provide guidance as to the locations of surfaces containing lead.

Contractors may use this information to better determine where worker exposures to airborne lead and other hazards may occur. They can then assess the potential magnitude of exposure to their employees and identify the controls necessary to limit health risks. This information can also be used for pre-characterization of demolition waste streams prior to toxicity characteristic leaching procedure (TCLP) sampling in accordance with 40 CFR Part 261.

Ten (10) samples, each from different homogenous areas, were collected during this survey. Paint chip samples were submitted under COC procedures to Scientific Analytical Institute Inc. (SAI) of Greensboro, North Carolina.

Analysis was conducted using EPA SW-846 Test Method 7000B: Flame Atomic Absorption Spectrophotometry.

3.3 LCP Results

A concentration of lead greater than or equal to 0.5 mg/Kg percent by weight or 1.0 mg/cm² exceeds EPA and HUD residential standards and is considered an indicator of risk. The results of this LCP sampling survey identified none of the samples that indicate risk and are presented in Table 2. The laboratory report and COC documentation are provided in Appendix C.

A/E Design Services for Pharmacy Physical Security Upgrades | G.V. Sonny Montgomery VAMC | Jackson, MS

© 2023, Mabbett & Associates, Inc. Page 5 April 30, 2023 Project No. R2023083.000 Miller-Remick Jackson VAMC Pharmacy RBM Survey Report Final

TABLE 2

Paint Chip Analytical Results

A/E Design Services for Pharmacy Physical Security Upgrades G.V. Sonny Montgomery VAMC

Sample No. Location Substrate and Component Color Result

(% by weight) Pb-01 Outpatient Pharmacy Metal Door Frame Gray 0.012% Pb-02 Outpatient Pharmacy Entry Gypsum Wall White <0.0033% Pb-03 Outpatient Pharmacy Metal Door Gray 0.0089% Pb-04 Outpatient Pharmacy Mens Room Plaster Wall Blue 0.049% Pb-05 Outpatient Pharmacy Gypsum Column White <0.0032% Pb-06 Inpatient Pharmacy (Entry) Metal Door Frame Tan <0.041% Pb-07 Inpatient Pharmacy (Shortage) Gypsum Wall Tan <0.0036%

Pb-08 Inpatient Pharmacy Metal Door Gray <0.0057%

Pb-09 Inpatient Pharmacy (Break Area) Gypsum Wall Blue <0.0067% Pb-10 Inpatient Pharmacy (Janitors Closet) Metal Door Frame Tan 0.0079%

A/E Design Services for Pharmacy Physical Security Upgrades | G.V. Sonny Montgomery VAMC | Jackson, MS

© 2023, Mabbett & Associates, Inc. Page 6 April 30, 2023 Project No. R2023083.000 Miller-Remick Jackson VAMC Pharmacy RBM Survey Report Final

4.0 RECOMMENDATIONS

4.1 Asbestos

Identified ACM must be removed by a licensed asbestos abatement contractor prior to being disturbed by renovation activities. Any suspect materials encountered during renovation or demolition activities that were not identified in this report as being non-ACM should be assumed to be ACM unless sample results prove otherwise.

Suspect ACM that may be present within the walls, above inaccessible hard ceilings, or in other inaccessible locations, should be assumed to contain asbestos if discovered during any renovation or demolition process or until otherwise verified.

4.2 Lead Containing Paint

Paint chip sampling conducted as part of this survey indicated that lead was not detected above the EPA limit of

0.5 mg/Kg percent by weight or 1.0 mg/cm² on a tested painted surface. The requirements under OSHA Standard 29 CFR 1926.62, Lead Exposure in Construction; Interim Final Rule, are applicable to renovation and demolition activities that disturb these materials.

OSHA does not recognize a “safe” level of lead in paint. Depending on the method of removal used, even trace amounts of lead in paint may result in airborne concentrations of lead during removal. An employer or contractor who disturbs or removes lead paint must comply with OSHA Standard 29 CFR 1926.62, Lead Exposure in Construction; Interim Final Rule.

Accordingly, this LCP survey cannot determine a safe level of lead for the purpose of paint-disturbing activities during the Pharmacy Upgrade project. This report is intended to provide guidance as to the location of LCP so it can be controlled, abated, and/or disposed of properly during the Pharmacy Upgrade project. The results of this survey should be used to determine where worker exposures to airborne lead may occur. Additionally, this information should also be used to assess the potential for exposure to workers, and for determining appropriate controls necessary to limit his or her health risks during this project.

Representative samples of LCP waste to be generated during building renovation, or following demolition but prior to disposal, should be collected and analyzed using toxicity characteristic leaching procedure (TCLP) in accordance with 40 CFR Part 261. Management and disposal of lead containing waste must be done in accordance with all applicable local, state, and federal regulations.

OSHA regulations may require certain procedures for any paint that contains lead, even if it does not exceed the residential standards. All LCP areas identified, regardless of the level of lead content, should either be sampled and analyzed using TCLP and then handled/disposed of accordingly, or segregated from other large-scale debris and managed as hazardous waste in accordance with federal, state, and local hazardous waste disposal regulations.

A/E Design Services for Pharmacy Physical Security Upgrades | G.V. Sonny Montgomery VAMC | Jackson, MS

© 2023, Mabbett & Associates, Inc. Appendix A April 30, 2023 Project No. R2023038.000 Miller-Remick Jackson VAMC Pharmacy RBM Survey Report Final

APPENDIX A

Summary of Asbestos Bulk Sampling Results

A/E Design Services for Pharmacy Physical Security Upgrades | G.V. Sonny Montgomery VAMC | Jackson, MS

© 2023, Mabbett & Associates, Inc. Appendix A April 30, 2023 Project No. R2023038.000 Miller-Remick Jackson VAMC Pharmacy RBM Survey Report Final

APPENDIX A

Summary of Asbestos Bulk Sampling Results

A/E Design Services for Pharmacy Physical Security Upgrades G.V. Sonny Montgomery VAMC

Sample No. Sample Location Description of Material

Percent and Type of

Asbestos A1 Outpatient Pharmacy 12” x 12” Tan Floor Tile with Specks and Black Mastic NAD

A1 Outpatient Pharmacy 12” x 12” Tan Floor Tile with Specks and Black Mastic NAD

A2 Outpatient Pharmacy 12” x 12’’ Tan Floor Tile with Specks and Black Mastic NAD

A2 Outpatient Pharmacy 12” x 12” Tan Floor Tile with Specks and Black Mastic NAD

A3 Outpatient Pharmacy 12” x 12” Tan Floor Tile with Specks and Black Mastic NAD

A3 Outpatient Pharmacy 12” x 12” Tan Floor Tile with Specks and Black Mastic NAD

A4 Outpatient Pharmacy White 12” x 12” Floor Tile with Specks and Yellow Mastic NAD

A4 Outpatient Pharmacy White 12” x 12” Floor Tile with Specks and Yellow Mastic NAD

A5 Outpatient Pharmacy White 12” x 12” Floor Tile with Specks and Yellow Mastic NAD

A5 Outpatient Pharmacy White 12” x 12” Floor Tile with Specks and Yellow Mastic NAD

A6 Outpatient Pharmacy White 12” x 12” Floor Tile with Specks and Yellow Mastic NAD

A6 Outpatient Pharmacy White 12” x 12” Floor Tile with Specks and Yellow Mastic NAD

A7 Outpatient Pharmacy Vinyl Wood Floor with Grey Adhesive NAD

A8 Outpatient Pharmacy Vinyl Wood Floor with grey Adhesive NAD

A9 Outpatient Pharmacy Vinyl Wood Floor with Grey Adhesive NAD

A10 Loading Dock Door Black Caulk NAD

A11 Loading Dock Door Black Caulk NAD

A12 Loading Dock Door Black Caulk NAD

A13 Loading Dock Brick Mortar NAD

A14 Loading Dock Brick Mortar NAD

A15 Loading Dock Brick Mortar NAD

A16 Loading Dock Orange 12” x 12” Floor Tile with Specks and Black Mastic NAD

A16 Loading Dock Orange 12” x 12” Floor Tile with Specks and Black Mastic NAD

A17 Loading Dock Orange 12” x 12” Floor Tile with Specks and Black Mastic NAD

A17 Loading Dock Orange 12” x 12” Floor Tile with Specks and Black Mastic NAD

A18 Loading Dock Orange 12” x 12” Floor Tile with Specks and Black Mastic NAD

A18 Loading Dock Orange 12” x 12” Floor Tile with Specks and Black Mastic NAD

A19 Loading Dock Grey Ceiling Texture NAD

A20 Loading Dock Grey Ceiling Texture NAD

A21 Loading Dock Grey Ceiling Texture NAD

A22 Loading Dock 4” Covebase with Yellow Adhesive NAD

A22 Loading Dock 4” Covebase with Yellow Adhesive NAD

A/E Design Services for Pharmacy Physical Security Upgrades | G.V. Sonny Montgomery VAMC | Jackson, MS

© 2023, Mabbett & Associates, Inc. Appendix A April 30, 2023 Project No. R2023038.000 Miller-Remick Jackson VAMC Pharmacy RBM Survey Report Final

APPENDIX A

Summary of Asbestos Bulk Sampling Results

A/E Design Services for Pharmacy Physical Security Upgrades G.V. Sonny Montgomery VAMC

Sample No. Sample Location Description of Material

Percent and Type of

Asbestos A23 Loading Dock 4” Covebase with Yellow Adhesive NAD

A23 Loading Dock 4” Covebase with Yellow Adhesive NAD

A24 Loading Dock 4” Covebase with Yellow Adhesive NAD

A24 Loading Dock 4” Covebase with Yellow Adhesive NAD

A25 Loading Dock Gypsum with Joint Compound NAD

A25 Loading Dock Gypsum with Joint Compound NAD

A26 Loading Dock Gypsum with Joint Compound NAD

A26 Loading Dock Gypsum with Joint Compound NAD

A27 Loading Dock Gypsum with Joint Compound NAD

A27 Loading Dock Gypsum with Joint Compound NAD

A28 Loading Dock 6” Covebase with Yellow Adhesive NAD

A28 Loading Dock 6” Covebase with Yellow Adhesive NAD

A29 Loading Dock 6” Covebase with Yellow Adhesive NAD

A29 Loading Dock 6” Covebase with Yellow Adhesive NAD

A30 Loading Dock 6” Covebase with Yellow Adhesive NAD

A30 Loading Dock 6” Covebase with Yellow Adhesive NAD

A31 Outpatient Pharmacy Plaster Wall NAD

A32 Outpatient Pharmacy Plaster Wall NAD

A33 Outpatient Pharmacy Plaster Wall NAD

A36 Outpatient Pharmacy Yellow Pipe Insulation with White/Silver Backing NAD

A37 Outpatient Pharmacy Yellow Pipe Insulation with White/Silver Backing NAD

A38 Outpatient Pharmacy Yellow Pipe Insulation with White/Silver Backing NAD

A34 Outpatient Pharmacy Black Sink Coat NAD

A35 Outpatient Pharmacy Black Sink Coat NAD

A39 Outpatient Pharmacy Tan Sprinkler Sealant NAD

A40 Outpatient Pharmacy Tan Sprinkler Sealant NAD

A41 Outpatient Pharmacy Tan Sprinkler Sealant NAD

A42 Outpatient Pharmacy 2’ x 4’ White Ceiling Tile Fissured NAD

A43 Outpatient Pharmacy 2’ x 4’ White Ceiling Tile Fissured NAD

A44 Outpatient Pharmacy 2’ x 4’ White Ceiling Tile Fissured NAD

A45 Outpatient Pharmacy Red Duct Sealant 10% Chrysotile

A46 Outpatient Pharmacy Red Duct Sealant 10% Chrysotile

A/E Design Services for Pharmacy Physical Security Upgrades | G.V. Sonny Montgomery VAMC | Jackson, MS

© 2023, Mabbett & Associates, Inc. Appendix A April 30, 2023

APPENDIX A

Summary of Asbestos Bulk Sampling Results

A/E Design Services for Pharmacy Physical Security Upgrades G.V. Sonny Montgomery VAMC

Sample No. Sample Location Description of Material

Percent and Type of

Asbestos A47 Outpatient Pharmacy Red Duct Sealant 10% Chrysotile

A48 Outpatient Pharmacy Red Fire Stop NAD

A49 Outpatient Pharmacy Red Fire Stop NAD

A50 Outpatient Pharmacy 2’ x 2’ White Ceiling Tile Fissured NAD

A51 Outpatient Pharmacy 2’ x 2’ White Ceiling Tile Fissured NAD

A52 Outpatient Pharmacy 2’ x 2’ White Ceiling Tile Fissured NAD

A53 Inpatient Pharmacy 2’ x 4’ White Ceiling Tile Fissured NAD

A54 Inpatient Pharmacy 2’ x 4’ White Ceiling Tile Fissured NAD

A55 Inpatient Pharmacy 2’ x 4’ White Ceiling Tile Fissured NAD

A56 Inpatient Pharmacy White Fiberglass End Sealant NAD

A57 Inpatient Pharmacy White Fiberglass End Sealant NAD

A58 Inpatient Pharmacy White Fiberglass End Sealant NAD

A59 Inpatient Pharmacy Gypsum with Joint Compound NAD

A60 Inpatient Pharmacy Gypsum with Joint Compound NAD

A61 Inpatient Pharmacy Gypsum with Joint Compound NAD

A62 Inpatient Pharmacy 2’ x 4’ White Ceiling Tile Smooth NAD

A63 Inpatient Pharmacy 2’ x 4’ White Ceiling Tile Smooth NAD

A64 Inpatient Pharmacy 2’ x 4’ White Ceiling Tile Smooth NAD

A65 Inpatient Pharmacy Tan Sprinkler Sealant NAD

A66 Inpatient Pharmacy Tan Sprinkler Sealant NAD

A67 Inpatient Pharmacy Tan Sprinkler Sealant NAD

A68 Inpatient Pharmacy Grey Duct Sealant NAD

A69 Inpatient Pharmacy Grey Duct Sealant NAD

A70 Inpatient Pharmacy Grey Duct Sealant NAD

Notes: NAD = No Asbestos Detected

A/E Design Services for Pharmacy Physical Security Upgrades | G.V. Sonny Montgomery VAMC | Jackson, MS

© 2023, Mabbett & Associates, Inc. Appendix B April 30, 2023

APPENDIX B

ECS Southeast Asbestos Survey Report

ASBESTOS SURVEY

VA MEDICAL CENTER - INPATIENT & OUTPATIENT PHARMACIES

1500 E WOODROW WILSON AVENUE

JACKSON, MISSISSIPPI 39216

ECS PROJECT NO. 49:20021

FOR: MABBETT & ASSOCIATES, INC.

APRIL 21, 2023

April 21, 2023

Mr. Michael Delaney

Mabbett & Associates, Inc.

105 Central Street

Suite 1400

Stoneham, Massachusetts 02180 delaney@mabbett.com

ECS Project No. 49:20021

Reference: Asbestos Survey, VA Medical Center - Inpatient & Outpatient Pharmacies, 1500 E Woodrow Wilson Avenue, Jackson, Mississippi

Dear Mr. Delaney:

ECS Southeast, LLP (ECS) is pleased to provide Mabbett & Associates, Inc. with the results of the above referenced Asbestos Survey performed at VA Medical Center - Inpatient & Outpatient Pharmacies located at 1500 E Woodrow Wilson Avenue in Jackson, Mississippi. This report summarizes our observations, analytical results, findings, and recommendations related to the work performed.

The work described in this report was performed by ECS in general accordance with the Scope of Services described in ECS Proposal Number 49:36899P and the terms and conditions of the agreement authorizing those services.

ECS appreciates this opportunity to provide Mabbett & Associates, Inc. with our services. If we can be of further assistance to you, please do not hesitate to contact us.

Sincerely, ECS Southeast, LLP

Taylor Pack Lindsey Thompson, REM Environmental Scientist Environmental Principal tpack@ecslimited.com lthompson@ecslimited.com 225-224-2583 502-493-7100

133 W. Oxmoor Road, Suite 205, Birmingham, Alabama 35209 • T: 205-588-5099 • F: 703-834-5527 • ecslimited.com NC Engineering No. F-1078 • NC Geology No. C-553 • SC Engineering No. 3239

EXECUTIVE SUMMARY

The subject property is improved with a hospital building reportedly originally constructed in the 1950s. The purpose of the survey was to determine if asbestos-containing materials (ACMs) are present on the subject property. Areas included in this survey were the Inpatient and Outpatient pharmacies, which are scheduled for renovation to upgrade finishes and repair security issues.

Based on the laboratory analysis of the bulk samples collected during the survey, the following materials were reported to contain asbestos:

• Red duct sealant in Outpatient Pharmacy

ECS assumes that the following materials contain asbestos, but the materials were not sampled:

• Fireproof doors

The executive summary is an integral portion of this report, however, ECS recommends the report be read in its entirety ii

PAGETABLE OF CONTENTS

1.0 SITE DESCRIPTION

2.0 PURPOSE

3.0 METHODOLOGY

3.1 Asbestos-Containing Materials

4.0 RESULTS

4.1 Asbestos-Containing Materials

4.2 Suspect or Assumed Asbestos-Containing Materials

5.0 RECOMMENDATIONS AND REGULATORY REQUIREMENTS

5.1 Asbestos-Containing Materials

6.0 LIMITATIONS

iii

TABLE OF APPENDICES

Appendix I: Figures

Appendix II: Site Photographs

Appendix III: Laboratory Report(s)

Appendix IV: Certifications/Licenses iv

1.0 SITE DESCRIPTION

The subject property is improved with a VA hospital building located at 1500 E Woodrow Wilson Avenue in Jackson, Mississippi. Sample areas include the Inpatient Pharmacy and Outpatient Pharmacy. Building finishes observed within the sample areas appeared to consist of floor tiles on concrete sub-floor, the wall systems consist of drywall, plaster walls, and/or brick walls, and the ceiling systems consist of a suspended drop ceiling which is composed of ceiling tiles and drywall.

2.0 PURPOSE

The purpose of the Asbestos Survey was to identify ACMs which may require special handling and/ or disposal if removed during construction activities. The identification of ACMs may require trained labor, regulated work practices, and special disposal.

3.0 METHODOLOGY

ECS performed the authorized Scope of Services in general accordance with our proposal, standard industry practice and methods specified by regulation for the identification of ACMs.

3.1 Asbestos-Containing Materials

The non-destructive asbestos survey was performed by an asbestos inspector who has received EPA accredited training and is licensed by Mississippi. Samples of suspect ACMs were collected utilizing hand tools and placed into individual, labeled plastic bags. Unique bulk suspect ACM samples were submitted to ESML in Baton Rouge, Louisiana for analysis via Polarized Light Microscopy (PLM) in accordance with current EPA-600 methodology. Materials consisting of additional layers were analyzed separately. ESML is listed as an accredited laboratory by the National Voluntary Laboratory Accreditation Plan (NVLAP) managed by the National Institute of Standards and Technology (NIST) for bulk sample analysis by currently approved EPA methodology by PLM.

During the survey, ECS attempted to identify suspect ACMs in readily accessible areas. However, due to the destructive means required to identify some materials, certain areas were deemed inaccessible (i.e. behind walls or sub grade materials) and were not surveyed for suspect ACMs. Unidentified suspect ACMs may be located in these and/or other inaccessible areas.

Samples were collected in general accordance with EPA Standard 40 CFR 763 Subpart E, Asbestos Hazard Emergency Response Act (AHERA) and OSHA Standard 29 CFR 1926.1101 Inspection Protocol.

Multiple samples of each unique material were submitted.

4.0 RESULTS

The following is a summary of laboratory results, findings and observations.

4.1 Asbestos-Containing Materials

In total, 70 bulk samples from 24 homogeneous areas were submitted to the laboratory of which 88 layers were analyzed.

April 21, 2023

ECS Project # 49:20021

Summary of Asbestos-Containing Materials Identified

Location Material Description Analytical Result Category

Outpatient Pharmacy

Red Duct Sealant (A-45, 46, 47)

10% Chrysotile Category II Non-Friable

4.2 Suspect or Assumed Asbestos-Containing Materials

Due to the inaccessibility or the destructive means that asbestos sampling requires, additional suspect ACMs may remain within the building hidden behind inaccessible areas that include, but are not limited to, sub-grade walls, structural members, topping slabs, sub-grade sealants, flooring located below underlayments, areas behind exterior walls, pipe trenches, and subsurface utilities, etc.

These areas were deemed inaccessible and were not assessed.

If these materials are discovered during construction activities, they should be presumed to contain asbestos and be treated as ACMs or be sampled immediately upon discovery and prior to disturbance for asbestos content by a certified asbestos inspector in accordance with 29 CFR 1926.1101.

5.0 RECOMMENDATIONS AND REGULATORY REQUIREMENTS

Based on our understanding of the purpose of the Asbestos Survey, the results of laboratory analysis, and our findings and observations, ECS presents the following recommendations.

5.1 Asbestos-Containing Materials

ECS recommends where a material type has been identified as asbestos-containing that other materials with similar color, texture, age and size throughout the building’s interior and exterior be assumed to contain asbestos. Please refer to Section 4.1 for a complete list of building materials that were reported positive for asbestos and to Section 4.2 for materials that were assumed to contain asbestos.

If ACMs are to be removed, it is recommended that an industrial hygienist monitor the project.

This involves collecting air samples from within and outside abatement work areas to monitor the asbestos abatement contractor’s work practices over the course of the project. The industrial hygienist should evaluate if the asbestos abatement work is in accordance with project specifications, U.S. EPA regulation 40 CFR Part 61-National Emission Standards for Hazardous Air Pollutants Subpart M: National Emission Standard for Asbestos, and U.S. Occupational Safety and Health Administration (OSHA) regulation 29 CFR 1926.1101 – Asbestos in Construction. The industrial hygienist should assess each work area to monitor the removal of ACMs. Only after the industrial hygienist has determined the identified ACMs have been removed should final clearance air samples be collected (if necessary).

Suspect ACMs not observed due to inaccessibility or not sampled due to the destructive means that sampling would require may also be encountered during construction activities. At the time of the survey, only limited destructive means were used to locate or sample suspect ACMs; therefore, additional suspect ACMs may remain within inaccessible areas that include, but are not limited

April 21, 2023 to, sub-grade walls, structural members, topping slabs, exterior areas, sub-grade sealants, flooring located below underlayments, vapor barriers, pipe trenches and other subsurface utilities, etc. If additional suspect ACMs are uncovered which were not accessible during this survey, it is recommended that these materials either be assumed to contain asbestos or be sampled prior to disturbance upon discovery for asbestos content by an asbestos inspector in accordance with 29 CFR 1926.1101.

6.0 LIMITATIONS

The conclusions and recommendations presented within this report are based upon a reasonable level of assessment within normal bounds and standards of professional practice for a site in this particular geographic setting. ECS is not responsible or liable for the discovery and elimination of hazards that may potentially cause damage, accidents, or injuries.

The observations, conclusions, and recommendations pertaining to environmental conditions at the subject site are necessarily limited to conditions observed, and/or materials reviewed at the time this study was undertaken. No warranty, expressed or implied, is made with regard to the conclusions and recommendations presented within this report. This report is provided for the exclusive use of the client. This report is not intended to be used or relied upon in connection with other projects or by other unidentified third parties without the written consent of ECS and the client.

Our recommendations are in part based on federal, state, and local regulations and guidelines. ECS does not assume the responsibility of the person(s) in charge of the site, or otherwise undertake responsibility for reporting to any local, state, or federal public agencies, any conditions at the site that may present a potential danger to public health, safety, or the environment. Under this scope of services, ECS assumes no responsibility regarding any response actions initiated as a result of these findings. General compliance with regulations and response actions are the sole responsibility of the Client and should be conducted in accordance with local, state, and/or federal requirements.

April 21, 2023

Appendix I: Figures

Legend:

A-# Asbestos Sample Location

Asbestos Sample Negative

Asbestos Sample Positive

Notes:

Not to scale

Figure 2 Asbestos Sample Locations (Outpatient

Pharmacy) VA Medical Center

1500 E Woodrow Wilson Ave Jackson, Mississippi

ECS Project No. 49:20021

A-23

A-22

A-21

A-20A-19

A-18 A-17 A-16

A-15

A-14

A-13

A-12 A-11

A-10

A-9

A-8 A-7

A-6 A-5

A-4

A-3

A-2

A-1

A-45

A-44

A-43

A-42

A-41 A-40

A-39 A-38 A-37 A-36

A-35 A-34

A-33A-32A-31

A-30

A-29 A-28

A-27

A-26

A-25

A-24

A-52

A-51

A-50

A-49A-48

A-47 A-46

Legend:

A-# Asbestos Sample Location

Asbestos Sample Negative

Notes:

Not to scale

Figure 3 Asbestos Sample Locations (Inpatient

Pharmacy Ceiling and Above) VA Medical Center

1500 E Woodrow Wilson Ave Jackson, Mississippi

ECS Project No. 49:20021

A-70 A-69

A-68

A-67

A-66

A-65

A-64

A-63

A-62 A-61

A-60

A-59

A-58 A-57 A-56

A-55

A-54

A-53

Appendix II: Site Photographs

1 - View of front of facility

2 - View of drywall and joint compound

3 - View of floor tiles and mastic

4 - View of 6 inch cove base

5 - View of ceiling tiles

6 - View of brick mortar, ceiling texture, and door sealant

7 - View of sprinkler sealant

8 - View of fire stop

9 - Typical view above drop ceiling

10 - View of 4 inch covebase

Appendix III: Laboratory Report(s)

EMSL Analytical, Inc.

18369 Petroleum Drive Baton Rouge, LA 70809

Tel/Fax: (225) 755-1920 / (225) 755-1989 http://www.EMSL.com / batonrougelab@emsl.com

252301822EMSL Order:

Customer ID: ENCS55

Customer PO:

Project ID:

Attention: Phone:Taylor Pack (225) 337-5567

Fax:ECS Southeast, LLP (864) 987-1615

Received Date:1200 Woodruff Road 04/13/2023 4:17 PM

Analysis Date:Suite H-12 04/19/2023

Collected Date:Greenville, SC 29607 04/13/2023

Project: VA Center Jackson 49:20021

Test Report: Asbestos Analysis of Bulk Materials via AHERA Method 40CFR 763 Subpart E

Appendix E supplemented with EPA 600/R-93/116 using Polarized Light Microscopy

Sample Description Appearance % Fibrous % Non-Fibrous

Non-Asbestos Asbestos

% Type

A-1-Floor Tile

252301822-0001

None DetectedNon-fibrous (Other)100%Gray/White

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Tan 12x12 floor tile w/specks & black mastic

HA: 1

A-1-Mastic

252301822-0001A

None DetectedNon-fibrous (Other)100%Black

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Tan 12x12 floor tile w/specks & black mastic

HA: 1

A-2-Floor Tile

252301822-0002

None DetectedNon-fibrous (Other)100%Tan/White

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Tan 12x12 floor tile w/specks & black mastic

HA: 1

A-2-Mastic

252301822-0002A

None DetectedNon-fibrous (Other)100%Black

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Tan 12x12 floor tile w/specks & black mastic

HA: 1

A-3-Floor Tile

252301822-0003

None DetectedNon-fibrous (Other)100%Gray/White

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Tan 12x12 floor tile w/specks & black mastic

HA: 1

A-3-Mastic

252301822-0003A

None DetectedNon-fibrous (Other)100%Black

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Tan 12x12 floor tile w/specks & black mastic

HA: 1

A-4-Floor Tile

252301822-0004

None DetectedNon-fibrous (Other)100%Tan/White

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- White 12x12 floor tile w/specks & yellow mastic

HA: 2

A-4-Adhesive

252301822-0004A

None DetectedNon-fibrous (Other)100%Yellow

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- White 12x12 floor tile w/specks & yellow mastic

HA: 2

A-5-Floor Tile

252301822-0005

None DetectedNon-fibrous (Other)100%Tan/White

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- White 12x12 floor tile w/specks & yellow mastic

HA: 2

A-5-Adhesive

252301822-0005A

None DetectedNon-fibrous (Other)100%Yellow

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- White 12x12 floor tile w/specks & yellow mastic

HA: 2

Initial report from: 04/20/2023 13:26:24

Page 1 of 7ASB_PLM_0008_0001 - 1.78 Printed: 4/20/2023 12:26 PM

Tel/Fax: (225) 755-1920 / (225) 755-1989 http://www.EMSL.com / batonrougelab@emsl.com

252301822EMSL Order:

Customer ID: ENCS55

Customer PO:

Project ID:

Test Report: Asbestos Analysis of Bulk Materials via AHERA Method 40CFR 763 Subpart E

Appendix E supplemented with EPA 600/R-93/116 using Polarized Light Microscopy

Sample Description Appearance % Fibrous % Non-Fibrous

Non-Asbestos Asbestos

% Type

A-6-Floor Tile

252301822-0006

None DetectedNon-fibrous (Other)100%Tan/White

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- White 12x12 floor tile w/specks & yellow mastic

HA: 2

A-6-Adhesive

252301822-0006A

None DetectedNon-fibrous (Other)100%Yellow

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- White 12x12 floor tile w/specks & yellow mastic

HA: 2

A-7

252301822-0007

None DetectedNon-fibrous (Other)100%Brown/Black

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Vinyl wood floor w/grey adhesive

HA: 3

A-8

252301822-0008

None DetectedNon-fibrous (Other)100%Brown/Black

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Vinyl wood floor w/grey adhesive

HA: 3

A-9

252301822-0009

None DetectedNon-fibrous (Other)100%Brown/Black

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Vinyl wood floor w/grey adhesive

HA: 3

A-10

252301822-0010

None DetectedNon-fibrous (Other)100%Black

Non-Fibrous

Homogeneous

Loading dock door -

Black caulk

HA: 4

A-11

252301822-0011

None DetectedNon-fibrous (Other)100%Black

Non-Fibrous

Homogeneous

Loading dock door -

Black caulk

HA: 4

A-12

252301822-0012

None DetectedNon-fibrous (Other)100%Black

Non-Fibrous

Homogeneous

Loading dock door -

Black caulk

HA: 4

A-13

252301822-0013

None DetectedNon-fibrous (Other)100%Gray/Red

Non-Fibrous

Heterogeneous

Loading dock - Brick mortar

HA: 5

A-14

252301822-0014

None DetectedNon-fibrous (Other)100%Gray/Red

Non-Fibrous

Homogeneous

Loading dock - Brick mortar

HA: 5

A-15

252301822-0015

None DetectedNon-fibrous (Other)100%Gray/Red

Non-Fibrous

Homogeneous

Loading dock - Brick mortar

HA: 5

A-16-Floor Tile

252301822-0016

None DetectedNon-fibrous (Other)100%Tan/White

Non-Fibrous

Homogeneous

Loading dock -

Orange 12x12 floor tile w/specks & black mastic

HA: 6

A-16-Mastic/Adhesive

252301822-0016A

None DetectedNon-fibrous (Other)100%Black/Yellow

Non-Fibrous

Homogeneous

Loading dock -

Orange 12x12 floor tile w/specks & black mastic

HA: 6

Page 2 of 7ASB_PLM_0008_0001 - 1.78 Printed: 4/20/2023 12:26 PM

Tel/Fax: (225) 755-1920 / (225) 755-1989 http://www.EMSL.com / batonrougelab@emsl.com

252301822EMSL Order:

Customer ID: ENCS55

Customer PO:

Project ID:

Test Report: Asbestos Analysis of Bulk Materials via AHERA Method 40CFR 763 Subpart E

Appendix E supplemented with EPA 600/R-93/116 using Polarized Light Microscopy

Sample Description Appearance % Fibrous % Non-Fibrous

Non-Asbestos Asbestos

% Type

A-17-Floor Tile

252301822-0017

None DetectedNon-fibrous (Other)100%Tan/White

Non-Fibrous

Homogeneous

Loading dock -

Orange 12x12 floor tile w/specks & black mastic

HA: 6

A-17-Mastic/Adhesive

252301822-0017A

None DetectedNon-fibrous (Other)100%Black/Yellow

Non-Fibrous

Homogeneous

Loading dock -

Orange 12x12 floor tile w/specks & black mastic

HA: 6

A-18-Floor Tile

252301822-0018

None DetectedNon-fibrous (Other)100%Tan/White

Non-Fibrous

Homogeneous

Loading dock -

Orange 12x12 floor tile w/specks & black mastic

HA: 6

A-18-Mastic/Adhesive

252301822-0018A

None DetectedNon-fibrous (Other)100%Black/Yellow

Non-Fibrous

Homogeneous

Loading dock -

Orange 12x12 floor tile w/specks & black mastic

HA: 6

A-19

252301822-0019

None DetectedNon-fibrous (Other)100%Gray/Tan

Non-Fibrous

Homogeneous

Loading dock - Grey ceiling texture

HA: 7

A-20

252301822-0020

None DetectedNon-fibrous (Other)100%Gray/Tan

Non-Fibrous

Homogeneous

Loading dock - Grey ceiling texture

HA: 7

A-21

252301822-0021

None DetectedNon-fibrous (Other)100%Gray/Tan

Non-Fibrous

Homogeneous

Loading dock - Grey ceiling texture

HA: 7

A-22-Cove Base

252301822-0022

None DetectedNon-fibrous (Other)100%Tan

Non-Fibrous

Homogeneous

Loading dock - 4in

Covebase w/yellow adhesive

HA: 8

A-22-Glue

252301822-0022A

None DetectedNon-fibrous (Other)100%Tan

Non-Fibrous

Homogeneous

Loading dock - 4in

Covebase w/yellow adhesive

HA: 8

A-23-Cove Base

252301822-0023

None DetectedNon-fibrous (Other)100%Gray

Non-Fibrous

Homogeneous

Loading dock - 4in

Covebase w/yellow adhesive

HA: 8

A-23-Glue

252301822-0023A

None DetectedNon-fibrous (Other)100%Tan

Non-Fibrous

Homogeneous

Loading dock - 4in

Covebase w/yellow adhesive

HA: 8

A-24-Cove Base

252301822-0024

None DetectedNon-fibrous (Other)100%Gray

Non-Fibrous

Homogeneous

Loading dock - 4in

Covebase w/yellow adhesive

HA: 8

A-24-Glue

252301822-0024A

None DetectedNon-fibrous (Other)100%Tan

Non-Fibrous

Homogeneous

Loading dock - 4in

Covebase w/yellow adhesive

HA: 8

A-25-Joint Compound

252301822-0025

None DetectedNon-fibrous (Other)100%Non-Fibrous

Homogeneous

Loading dock -

Gypsum w/joint compound

Page 3 of 7ASB_PLM_0008_0001 - 1.78 Printed: 4/20/2023 12:26 PM

Tel/Fax: (225) 755-1920 / (225) 755-1989 http://www.EMSL.com / batonrougelab@emsl.com

252301822EMSL Order:

Customer ID: ENCS55

Customer PO:

Project ID:

Test Report: Asbestos Analysis of Bulk Materials via AHERA Method 40CFR 763 Subpart E

Appendix E supplemented with EPA 600/R-93/116 using Polarized Light Microscopy

Sample Description Appearance % Fibrous % Non-Fibrous

Non-Asbestos Asbestos

% Type

HA: 9

A-25-Drywall

252301822-0025A

None DetectedNon-fibrous (Other)100%Gray

Non-Fibrous

Homogeneous

Loading dock -

Gypsum w/joint compound

HA: 9

A-26-Joint Compound

252301822-0026

None DetectedNon-fibrous (Other)100%White

Non-Fibrous

Homogeneous

Loading dock -

Gypsum w/joint compound

HA: 9

A-26-Drywall

252301822-0026A

None DetectedNon-fibrous (Other)100%Gray

Non-Fibrous

Homogeneous

Loading dock -

Gypsum w/joint compound

HA: 9

A-27-Joint Compound

252301822-0027

None DetectedNon-fibrous (Other)100%White

Non-Fibrous

Homogeneous

Loading dock -

Gypsum w/joint compound

HA: 9

A-27-Drywall

252301822-0027A

None DetectedNon-fibrous (Other)100%Gray

Non-Fibrous

Homogeneous

Loading dock -

Gypsum w/joint compound

HA: 9

A-28-Cove Base

252301822-0028

None DetectedNon-fibrous (Other)100%Gray

Non-Fibrous

Homogeneous

Loading dock - 6in

Covebased w/yellow adhesive

HA: 10

A-28-Glue

252301822-0028A

None DetectedNon-fibrous (Other)100%Tan

Non-Fibrous

Homogeneous

Loading dock - 6in

Covebased w/yellow adhesive

HA: 10

A-29-Cove Base

252301822-0029

None DetectedNon-fibrous (Other)100%Gray

Non-Fibrous

Homogeneous

Loading dock - 6in

Covebased w/yellow adhesive

HA: 10

A-29-Glue

252301822-0029A

None DetectedNon-fibrous (Other)100%Tan

Non-Fibrous

Homogeneous

Loading dock - 6in

Covebased w/yellow adhesive

HA: 10

A-30-Cove Base

252301822-0030

None DetectedNon-fibrous (Other)100%Gray

Non-Fibrous

Homogeneous

Loading dock - 6in

Covebased w/yellow adhesive

HA: 10

A-30-Glue

252301822-0030A

None DetectedNon-fibrous (Other)100%Tan

Non-Fibrous

Homogeneous

Loading dock - 6in

Covebased w/yellow adhesive

HA: 10

A-31

252301822-0031

None DetectedNon-fibrous (Other)100%White

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Plaster Wall

HA: 11

A-32

252301822-0032

None DetectedNon-fibrous (Other)100%White

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Plaster Wall

HA: 11

A-33

252301822-0033

None DetectedNon-fibrous (Other)100%White

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Plaster Wall

HA: 11

Page 4 of 7ASB_PLM_0008_0001 - 1.78 Printed: 4/20/2023 12:26 PM

Tel/Fax: (225) 755-1920 / (225) 755-1989 http://www.EMSL.com / batonrougelab@emsl.com

252301822EMSL Order:

Customer ID: ENCS55

Customer PO:

Project ID:

Test Report: Asbestos Analysis of Bulk Materials via AHERA Method 40CFR 763 Subpart E

Appendix E supplemented with EPA 600/R-93/116 using Polarized Light Microscopy

Sample Description Appearance % Fibrous % Non-Fibrous

Non-Asbestos Asbestos

% Type

A-36

252301822-0034

None DetectedNon-fibrous (Other)20%Glass80%Tan/Silver/Yellow

Non-Fibrous

Heterogeneous

Outpatient Pharmacy

- Yellow pipe insallation w/white/silver backing

HA: 13

A-37

252301822-0035

None DetectedNon-fibrous (Other)20%Glass80%Tan/Silver/Yellow

Fibrous

Heterogeneous

Outpatient Pharmacy

- Yellow pipe insallation w/white/silver backing

HA: 13

A-38

252301822-0036

None DetectedNon-fibrous (Other)20%Glass80%Tan/Silver/Yellow

Fibrous

Heterogeneous

Outpatient Pharmacy

- Yellow pipe insallation w/white/silver backing

HA: 13

A-34

252301822-0037

None DetectedNon-fibrous (Other)100%Black

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Black sink coat

HA: 12

A-35

252301822-0038

None DetectedNon-fibrous (Other)100%Black

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Black sink coat

HA: 12

A-39

252301822-0039

None DetectedNon-fibrous (Other)100%Tan

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Tan sprinkler sealant

HA: 14

A-40

252301822-0040

None DetectedNon-fibrous (Other)100%Tan

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Tan sprinkler sealant

HA: 14

A-41

252301822-0041

None DetectedNon-fibrous (Other)100%Tan

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Tan sprinkler sealant

HA: 14

A-42

252301822-0042

None DetectedNon-fibrous (Other)35%Cellulose

Glass

50%

15%

Gray/Tan/White

Fibrous

Homogeneous

Outpatient Pharmacy

- White 4x2 ceiling tile fissured

HA: 15

A-43

252301822-0043

None DetectedNon-fibrous (Other)35%Cellulose

Glass

50%

15%

Gray/Tan/White

Fibrous

Homogeneous

Outpatient Pharmacy

- White 4x2 ceiling tile fissured

HA: 15

A-44

252301822-0044

None DetectedNon-fibrous (Other)35%Cellulose

Glass

50%

15%

Gray/Tan/White

Fibrous

Homogeneous

Outpatient Pharmacy

- White 4x2 ceiling tile fissured

HA: 15

A-45

252301822-0045

10% ChrysotileNon-fibrous (Other)90%Red

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Red duct sealant

HA: 16

A-46

252301822-0046

10% ChrysotileNon-fibrous (Other)90%Red

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Red duct sealant

HA: 16

A-47

252301822-0047

10% ChrysotileNon-fibrous (Other)90%Red

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Red duct sealant

HA: 16

Page 5 of 7ASB_PLM_0008_0001 - 1.78 Printed: 4/20/2023 12:26 PM

Tel/Fax: (225) 755-1920 / (225) 755-1989 http://www.EMSL.com / batonrougelab@emsl.com

252301822EMSL Order:

Customer ID: ENCS55

Customer PO:

Project ID:

Test Report: Asbestos Analysis of Bulk Materials via AHERA Method 40CFR 763 Subpart E

Appendix E supplemented with EPA 600/R-93/116 using Polarized Light Microscopy

Sample Description Appearance % Fibrous % Non-Fibrous

Non-Asbestos Asbestos

% Type

A-48

252301822-0048

None DetectedNon-fibrous (Other)100%Red

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Red fire stop

HA: 17

A-49

252301822-0049

None DetectedNon-fibrous (Other)100%Red

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- Red fire stop

HA: 17

A-50

252301822-0050

None DetectedNon-fibrous (Other)35%Cellulose

Glass

50%

15%

Gray/Tan/White

Fibrous

Homogeneous

Outpatient Pharmacy

- White 2x2w ceiling tile fissured

HA: 18

A-51

252301822-0051

None DetectedNon-fibrous (Other)35%Cellulose

Glass

50%

15%

Gray/Tan/White

Fibrous

Homogeneous

Outpatient Pharmacy

- White 2x2w ceiling tile fissured

HA: 18

A-52

252301822-0052

None DetectedNon-fibrous (Other)35%Cellulose

Glass

50%

15%

Gray/Tan/White

Non-Fibrous

Homogeneous

Outpatient Pharmacy

- White 2x2w ceiling tile fissured

HA: 18

A-53

252301822-0053

None DetectedNon-fibrous (Other)35%Cellulose

Glass

50%

15%

Gray/Tan/White

Fibrous

Homogeneous

Inpatient Pharmacy -

White 4x2 fissured ceiling tile

HA: 19

A-54

252301822-0054

None DetectedNon-fibrous (Other)35%Cellulose

Glass

50%

15%

Gray/Tan/White

Fibrous

Homogeneous

Inpatient Pharmacy -

White 4x2 fissured ceiling tile

HA: 19

A-55

252301822-0055

None DetectedNon-fibrous (Other)35%Cellulose

Glass

50%

15%

Gray/Tan/White

Fibrous

Homogeneous

Inpatient Pharmacy -

White 4x2 fissured ceiling tile

HA: 19

A-56

252301822-0056

None DetectedNon-fibrous (Other)100%White/Yellow

Non-Fibrous

Homogeneous

Inpatient Pharmacy -

White fiberglass end sealant

HA: 20

A-57

252301822-0057

None DetectedNon-fibrous (Other)100%White/Yellow

Non-Fibrous

Homogeneous

Inpatient Pharmacy -

White fiberglass end sealant

HA: 20

A-58

252301822-0058

None DetectedNon-fibrous (Other)100%White/Yellow

Non-Fibrous

Homogeneous

Inpatient Pharmacy -

White fiberglass end sealant

HA: 20

A-59

252301822-0059

None DetectedNon-fibrous (Other)100%Peach

Non-Fibrous

Homogeneous

Inpatient Pharmacy -

Gypsum w/joint compound

HA: 21

A-60

252301822-0060

None DetectedNon-fibrous (Other)100%Gray

Non-Fibrous

Homogeneous

Inpatient Pharmacy -

Gypsum w/joint compound

HA: 21

A-61

252301822-0061

None DetectedNon-fibrous (Other)100%Gray

Non-Fibrous

Homogeneous

Inpatient Pharmacy -

Gypsum w/joint compound

HA: 21

Page 6 of 7ASB_PLM_0008_0001 - 1.78 Printed: 4/20/2023 12:26 PM

Tel/Fax: (225) 755-1920 / (225) 755-1989 http://www.EMSL.com / batonrougelab@emsl.com

252301822EMSL Order:

Customer ID: ENCS55

Customer PO:

Project ID:

Test Report: Asbestos Analysis of Bulk Materials via AHERA Method 40CFR 763 Subpart E

Appendix E supplemented with EPA 600/R-93/116 using Polarized Light Microscopy

Sample Description Appearance % Fibrous % Non-Fibrous

Non-Asbestos Asbestos

% Type

A-62

252301822-0062

None DetectedNon-fibrous (Other)20%Glass80%White/Yellow

Fibrous

Homogeneous

Inpatient Pharmacy -

White 4x2 smooth ceiling tile

HA: 22

A-63

252301822-0063

None DetectedNon-fibrous (Other)20%Glass80%White/Yellow

Non-Fibrous

Homogeneous

Inpatient Pharmacy -

White 4x2 smooth ceiling tile

HA: 22

A-64

252301822-0064

None DetectedNon-fibrous (Other)20%Glass80%White/Yellow

Non-Fibrous

Homogeneous

Inpatient Pharmacy -

White 4x2 smooth ceiling tile

HA: 22

A-65

252301822-0065

None DetectedNon-fibrous (Other)100%Gray/Tan

Non-Fibrous

Homogeneous

Inpatient Pharmacy -

Tan sprinkler sealant

HA: 23

A-66

252301822-0066

None DetectedNon-fibrous (Other)100%Gray/Tan

Non-Fibrous

Homogeneous

Inpatient Pharmacy -

Tan sprinkler sealant

HA: 23

A-67

252301822-0067

None DetectedNon-fibrous (Other)100%Gray/Tan

Non-Fibrous

Homogeneous

Inpatient Pharmacy -

Tan sprinkler sealant

HA: 23

A-68

252301822-0068

None DetectedNon-fibrous (Other)100%Gray

Non-Fibrous

Homogeneous

Inpatient Pharmacy -

Grey duct sealant

HA: 24

A-69

252301822-0069

None DetectedNon-fibrous (Other)100%Gray

Non-Fibrous

Homogeneous

Inpatient Pharmacy -

Grey duct sealant

HA: 24

A-70

252301822-0070

None DetectedNon-fibrous (Other)100%Gray

Non-Fibrous

Homogeneous

Inpatient Pharmacy -

Grey duct sealant

HA: 24

A…